Clinical Trial Update: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial [NA]

View source ↗

Summary

Global post-market randomized trial of the VenaSeal Closure System for venous reflux in chronic venous insufficiency was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicose Veins
• Venous Insufficiency

Drugs mentioned

• VenaSeal Closure System

Snippet

Sponsor: Medtronic Endovascular | Conditions: Venous Reflux | NA | Status: TERMINATED | Results posted: 2025-09-04